Michael Cantrell, Vice President, US Cell Therapy Medical Affairs at Bristol Myers Squibb, shared a post on LiknedIn:
“Huge shout-out to the teams who made this possible. The passion and collaboration across SWOG, BMS, and many partners turned a massive investigator-sponsored trial into a filing-ready package—an incredible achievement. Proud of this team and excited for the patients who will benefit.”
Other articles about Hodgkin Lymphoma on OncoDaily.